胸心外科

订阅

MedSci主页 / 所有栏目 / 胸心外科

reverse crush stent治疗LAD-D1分叉部支架内再狭窄病（图）

2015-12-02 网络 MedSci原创

医学图片
关注

reverse crush stent治疗LAD-D1分叉部支架内再狭窄病

reverse crush stent治疗LAD-D1分叉部支架内再狭窄病

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1985865, encodeId=03ea198586570, content=<a href='/topic/show?id=20605e09148' target=_blank style='color:#2F92EE;'>#支架内再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57091, encryptionId=20605e09148, topicName=支架内再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Oct 11 22:12:00 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005527, encodeId=e222200552e85, content=<a href='/topic/show?id=7e0315401a8' target=_blank style='color:#2F92EE;'>#reverse#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15401, encryptionId=7e0315401a8, topicName=reverse)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Jun 21 20:12:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795090, encodeId=435b1e95090e6, content=<a href='/topic/show?id=281d16e9379' target=_blank style='color:#2F92EE;'>#Stent#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16793, encryptionId=281d16e9379, topicName=Stent)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sat Mar 05 16:12:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878137, encodeId=c07818e8137b6, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Apr 19 00:12:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486187, encodeId=4067148618e42, content=<a href='/topic/show?id=15b93065283' target=_blank style='color:#2F92EE;'>#再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30652, encryptionId=15b93065283, topicName=再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8f8090913, createdName=12498f1em10(暂无昵称), createdTime=Fri Dec 04 00:12:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2016-10-11 ms3025846204744509

    #支架内再狭窄#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1985865, encodeId=03ea198586570, content=<a href='/topic/show?id=20605e09148' target=_blank style='color:#2F92EE;'>#支架内再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57091, encryptionId=20605e09148, topicName=支架内再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Oct 11 22:12:00 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005527, encodeId=e222200552e85, content=<a href='/topic/show?id=7e0315401a8' target=_blank style='color:#2F92EE;'>#reverse#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15401, encryptionId=7e0315401a8, topicName=reverse)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Jun 21 20:12:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795090, encodeId=435b1e95090e6, content=<a href='/topic/show?id=281d16e9379' target=_blank style='color:#2F92EE;'>#Stent#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16793, encryptionId=281d16e9379, topicName=Stent)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sat Mar 05 16:12:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878137, encodeId=c07818e8137b6, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Apr 19 00:12:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486187, encodeId=4067148618e42, content=<a href='/topic/show?id=15b93065283' target=_blank style='color:#2F92EE;'>#再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30652, encryptionId=15b93065283, topicName=再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8f8090913, createdName=12498f1em10(暂无昵称), createdTime=Fri Dec 04 00:12:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2016-06-21 zengjiayao

    #reverse#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1985865, encodeId=03ea198586570, content=<a href='/topic/show?id=20605e09148' target=_blank style='color:#2F92EE;'>#支架内再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57091, encryptionId=20605e09148, topicName=支架内再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Oct 11 22:12:00 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005527, encodeId=e222200552e85, content=<a href='/topic/show?id=7e0315401a8' target=_blank style='color:#2F92EE;'>#reverse#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15401, encryptionId=7e0315401a8, topicName=reverse)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Jun 21 20:12:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795090, encodeId=435b1e95090e6, content=<a href='/topic/show?id=281d16e9379' target=_blank style='color:#2F92EE;'>#Stent#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16793, encryptionId=281d16e9379, topicName=Stent)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sat Mar 05 16:12:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878137, encodeId=c07818e8137b6, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Apr 19 00:12:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486187, encodeId=4067148618e42, content=<a href='/topic/show?id=15b93065283' target=_blank style='color:#2F92EE;'>#再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30652, encryptionId=15b93065283, topicName=再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8f8090913, createdName=12498f1em10(暂无昵称), createdTime=Fri Dec 04 00:12:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2016-03-05 zhixianchen

    #Stent#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1985865, encodeId=03ea198586570, content=<a href='/topic/show?id=20605e09148' target=_blank style='color:#2F92EE;'>#支架内再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57091, encryptionId=20605e09148, topicName=支架内再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Oct 11 22:12:00 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005527, encodeId=e222200552e85, content=<a href='/topic/show?id=7e0315401a8' target=_blank style='color:#2F92EE;'>#reverse#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15401, encryptionId=7e0315401a8, topicName=reverse)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Jun 21 20:12:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795090, encodeId=435b1e95090e6, content=<a href='/topic/show?id=281d16e9379' target=_blank style='color:#2F92EE;'>#Stent#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16793, encryptionId=281d16e9379, topicName=Stent)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sat Mar 05 16:12:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878137, encodeId=c07818e8137b6, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Apr 19 00:12:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486187, encodeId=4067148618e42, content=<a href='/topic/show?id=15b93065283' target=_blank style='color:#2F92EE;'>#再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30652, encryptionId=15b93065283, topicName=再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8f8090913, createdName=12498f1em10(暂无昵称), createdTime=Fri Dec 04 00:12:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2016-04-19 仁者大医

    #ERS#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1985865, encodeId=03ea198586570, content=<a href='/topic/show?id=20605e09148' target=_blank style='color:#2F92EE;'>#支架内再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57091, encryptionId=20605e09148, topicName=支架内再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Oct 11 22:12:00 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005527, encodeId=e222200552e85, content=<a href='/topic/show?id=7e0315401a8' target=_blank style='color:#2F92EE;'>#reverse#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15401, encryptionId=7e0315401a8, topicName=reverse)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Jun 21 20:12:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795090, encodeId=435b1e95090e6, content=<a href='/topic/show?id=281d16e9379' target=_blank style='color:#2F92EE;'>#Stent#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16793, encryptionId=281d16e9379, topicName=Stent)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sat Mar 05 16:12:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878137, encodeId=c07818e8137b6, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Apr 19 00:12:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486187, encodeId=4067148618e42, content=<a href='/topic/show?id=15b93065283' target=_blank style='color:#2F92EE;'>#再狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30652, encryptionId=15b93065283, topicName=再狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8f8090913, createdName=12498f1em10(暂无昵称), createdTime=Fri Dec 04 00:12:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-04 12498f1em10(暂无昵称)

    #再狭窄#

    0

相关资讯

伴重度肺动脉高压动脉导管未闭患者的介入治疗（图）

伴重度肺动脉高压动脉导管未闭患者的介入治疗

OTW 球囊和Kissing Stenting技术在左主干急性闭塞中的

OTW 球囊和Kissing Stenting技术在左主干急性闭塞中的

PCI与尿激酶联合应用成功治疗左前降支血栓性病变（图）

PCI与尿激酶联合应用成功治疗左前降支血栓性病变

不同DES在CTO病变中的复合应用

RCA慢性闭塞病变（OMI）成功血运重建

RCA慢性闭塞病变（OMI）成功血运重建

PCI干预LAD导致LM撕裂（图）